Picture EBD Group BioPharm America 2019 Boston September 600x60px
Organisation › Details

4D Pharma (Group)

Founded in February 2014, 4D pharma is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D pharma has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D pharma's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D pharma currently has a pipeline of 13 development programmes, including disease areas such as rheumatoid arthritis, multiple sclerosis and cancer, and is currently conducting patient trials in IBS and Paediatric Crohn's. The programmes in Paediatric Colitis and Paediatric Crohn's have both been granted Orphan Drug Status by the FDA. *


Period Start 2014-02-01 established
  Today 4D Pharma plc (AIM: DDDD)
Products Industry pharmaceutical
  Industry 2 MicroRx platform
Region Region Leeds, West Yorkshire
  Country United Kingdom (GB)
  Street 9 Bond Court
  City LS1 2JZ Leeds
    Address record changed: 2016-02-16
Basic data Employees n. a.
    * Document for �About Section�: 4D Pharma plc. (2/10/16). "Press Release: Acquisition [of Tucana Health Ltd.]".
Record changed: 2017-09-10


Picture [LSUS] – The Business Web Portal 600x60px

More documents for 4D Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top